Clinical Trial Update: Pre-op Rectal ChemoRad +/- Cetuximab [Phase 2]

View source ↗

Summary

Phase 2 study evaluating preoperative chemoradiation with or without cetuximab in rectal cancer. The trial is completed and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: US Oncology Research | Conditions: Rectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-11-03